BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7744257)

  • 1. Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL.
    Root-Bernstein RS; DeWitt SH
    Genetica; 1995; 95(1-3):133-56. PubMed ID: 7744257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic complementarity among AIDS-associated infectious agents and molecular mimicry of lymphocyte proteins as inducers of lymphocytotoxic antibodies and circulating immune complexes.
    Root-Bernstein RS
    J Clin Virol; 2004 Dec; 31 Suppl 1():S16-25. PubMed ID: 15567090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 similarity to proteins of infectious agents in AIDS and their role in autoimmunity.
    Root-Bernstein RS; Dewitt SH
    Med Hypotheses; 1994 Dec; 43(6):361-71. PubMed ID: 7739408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic complementarity between HIV and other AIDS-associated infections results in idiotype-antiidiotype antibody complexes that cross react with lymphocyte proteins.
    Root-Bernstein R
    Vaccine; 2005 Mar; 23(17-18):2160-3. PubMed ID: 15755587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of lymphopenia in HIV infection].
    Roger PM; Pradier C; Dellamonica P
    Presse Med; 1994 Jan; 23(2):89-94. PubMed ID: 7908132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A response to P.H. Duesberg with reference to an idiotypic network model of AIDS immunopathogenesis.
    Hoffmann GW
    Res Immunol; 1990 Oct; 141(8):701-9. PubMed ID: 2089529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytotoxic antibodies in the acquired immune deficiency syndrome (AIDS).
    Kloster BE; Tomar RH; Spira TJ
    Clin Immunol Immunopathol; 1984 Feb; 30(2):330-5. PubMed ID: 6607146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes.
    Adams LE; Donovan-Brand R; Friedman-Kien A; el Ramahi K; Hess EV
    Clin Immunol Immunopathol; 1988 Mar; 46(3):442-9. PubMed ID: 3257434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle.
    Bisset LR
    Med Hypotheses; 1994 Dec; 43(6):388-96. PubMed ID: 7739411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic.
    Evans BA; McCormack SM; Bond RA; MacRae KD; Thorp RW
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):473-5. PubMed ID: 3126866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
    de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
    Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of lymphocytotoxic antibodies in AIDS and pre-AIDS patients.
    Wicher V; Wicher K; Esparza B
    AIDS Res; 1983-1984; 1(2):139-48. PubMed ID: 6242700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners.
    Ozturk GE; Kohler PF; Horsburgh CR; Kirkpatrick CH
    J Clin Immunol; 1987 Mar; 7(2):130-9. PubMed ID: 3033011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
    Golding H; Shearer GM; Hillman K; Lucas P; Manischewitz J; Zajac RA; Clerici M; Gress RE; Boswell RN; Golding B
    J Clin Invest; 1989 Apr; 83(4):1430-5. PubMed ID: 2467924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cytotoxic peptide as possible mechanism for neurotoxicity of HIV viral envelope and AIDS pathogenesis.
    Sangster B
    Med Hypotheses; 1997 Jun; 48(6):463-8. PubMed ID: 9247885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does HIV "piggyback" on CD4-like surface proteins of sperm, viruses, and bacteria? Implications for co-transmission, cellular tropism and the induction of autoimmunity in AIDS.
    Root-Bernstein RS; Hobbs SH
    J Theor Biol; 1993 Jan; 160(2):249-64. PubMed ID: 8474253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-HLA lymphocytotoxic antibodies in HIV-seropositive and HIV-seronegative hemophiliacs.
    Conte R; Giovanardi L; Tazzari PL; De Rosa V; Rodorigo G; Re MC
    Vox Sang; 1988; 54(1):47-51. PubMed ID: 3258080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.